Clinical Medicine Research

Special Issue

Globalization and Advances on Non-Communicable Chronic Diseases

  • Submission Deadline: Jan. 10, 2020
  • Status: Submission Closed
  • Lead Guest Editor: Daniel López-Hernández
About This Special Issue
The growing global burden of non-communicable diseases around the world is a public health and politic problem. Despite the strong evidence, the preventability of its causes has been inadequate. Globalization is an important determinant of non-communicable disease epidemics since it has direct effects on risks to populations and indirect effects on national economies and health systems. Today, non-communicable chronic diseases are sweeping the entire globe. There is an increasing trend in developing countries, where the demographic and socio-economic transition imposes more constraints on dealing with the double burden of infectious and non-infectious diseases in a poor environment, characterized by ill-health systems. It is predicted that, by 2020, non-communicable chronic diseases will cause seven out of every ten deaths in developing countries. Among non-communicable chronic diseases, special attention is devoted to cardiovascular disease, diabetes, cancer and chronic pulmonary disease, because 63% of all deaths worldwide currently stem from non-communicable chronic disease – chiefly cardiovascular diseases, cancers, chronic respiratory diseases and diabetes. The burden of these conditions affects countries worldwide but with a growing trend in developing countries. Moreover, recent investigations show that many of these diseases share common pathophysiological mechanisms and are, at least in part, different and / or similar molecular alterations.

Aims and Scope:

  1. Clinical Studies
  2. Public health investigations
  3. Clinical trials
  4. Studies on prevention, control and management of non-communicable chronic diseases
  5. Studies on Patient education and Counseling
  6. Basic advances on non-communicable chronic diseases
Lead Guest Editor
  • Daniel López-Hernández

    Quality Department, Clínica de Medicina Familiar "División del Norte", Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado (ISSSTE), Mexico City, Mexico

Guest Editors
  • María de la Luz López-Hernández

    pidemiology and Biostatitics Departament. Center for Research and Continuing Education S.C, Mexico City, Mexico

  • Emanuel Melgarejo-Estefan

    Programming and Development Department, Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado (ISSSTE), Mexico City, Mexico

  • Leticia Brito-Aranda

    Biostatistical and Epidemiology Department, Centro de Investigación y de Educación Continua S.C., Mexico City, Mexico

Published Articles
  • Natural killer T Cells: A Powerful Via in the Regulation of Non Communicable Chronic Diseases

    Carlos Ramirez-Velazquez , Juan Carlos Paredes-Palma , Sandra Vanesa Patzi-Vargas

    Issue: Volume 8, Issue 6, November 2019
    Pages: 137-143
    Received: Oct. 13, 2019
    Accepted: Nov. 12, 2019
    Published: Dec. 17, 2019
    DOI: 10.11648/j.cmr.20190806.12
    Abstract: The Natural Killer T cells (NKT) constitute a population of T lymphocytes that co-express an antigen receptor (TCR) and a marker of natural killer cells (NK1.1). We have found that after stimulation through TCR, the NKT cells secrete various cytokines that play an important role in the innate immune response and have a fundamental participation in ... Show More
  • Efficacy of Risedronate and Vitamin D3 Once-weekly on Bone Mineral Density in Women Patients with Osteoporosis

    Daniel Lopez-Hernandez , Nadhyieli Orozco-Campos , Leticia Brito-Aranda , Maria de la Luz Lopez-Hernandez , Aurora Bautista-Marquez , Vesta Richardson

    Issue: Volume 8, Issue 5, September 2019
    Pages: 93-100
    Received: Aug. 10, 2019
    Accepted: Sep. 10, 2019
    Published: Sep. 30, 2019
    DOI: 10.11648/j.cmr.20190805.11
    Abstract: There has been a limited evaluation of the efficacy of administered vitamin-D3 and bisphosphonate in a single pill (once-weekly) on changes of Bone Mineral Density (BMD), speciality in elderly people. To evaluate the changes in BMD, using Risedronate and vitamin D3, in patients from the first level of primary care after a period of more than 2 year... Show More